Stockreport

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb

2seventy bio, Inc.  (TSVT) 
PDF $5.00 per share, all-cash transactionExpected to close in the second quarter of 2025, subject to customary closing conditions CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seve [Read more]